Therapeutic application of 3B-PEG injectable hydrogel/Nell-1 composite system to temporomandibular joint osteoarthritis

PEG比率 骨关节炎 材料科学 聚乙二醇 体内 生物医学工程 生物相容性 化学 医学 病理 生物化学 生物 生物技术 经济 冶金 替代医学 财务
作者
Chen‐Yu Wang,Yingnan Wang,Cunyi Wang,Chao Liu,Wen Li,Shiyu Hu,Na Wu,Shijie Jiang,Jiejun Shi
出处
期刊:Biomedical Materials [IOP Publishing]
卷期号:17 (1): 015004-015004 被引量:5
标识
DOI:10.1088/1748-605x/ac367f
摘要

Abstract This study aims to construct a composite system of the tri-block polyethylene glycol injectable hydrogel (3B-PEG IH) and neural epithelial growth factor-like protein 1 (Nell-1), and to analyze its therapeutic effect on temporomandibular joint osteoarthritis (TMJOA). Sol-gel transition temperature was measured via inverting test. The viscoelastic modulus curves was measured by rheometer. Degradation and controlled release profiles of 3B-PEG IH were drawn in vitro . In vivo gel retention and biocompatibility were completed subcutaneously on the back of rats. After primary chondrocytes were extracted and identified, the cell viability in 3B-PEG IH was measured. Evaluation of gene expression in hydrogel was performed by real-time polymerase chain reaction. TMJOA rabbits were established by intra-articular injection of type II collagenase. Six weeks after composite systems being injected, gross morphological score, micro-CT, histological staining and grading were evaluated. The rusults showed that different types of 3B-PEG IH all reached a stable gel state at 37 °C and could support the three-dimensional growth of chondrocytes, but poly(lactide-co-caprolactone)-block-poly(ethyleneglycol)-block-poly(lactide-co-caprolactone) (PLCL-PEG-PLCL) hydrogel had a wider gelation temperature range and better hydrolytic stability for about 4 weeks. Its controlled release curve is closest to the zero-order release kinetics. In vitro , PLCL-PEG-PLCL/Nell-1 could promote the chondrogenic expression and reduce the inflammatory expression. In vivo , TMJOA rabbits were mainly characterized by the disorder of cartilage structure and the destruction of subchondral bone. However, PLCL-PEG-PLCL/Nell-1 could reverse the destruction of the subchondral trabecula, restore the fibrous and proliferative layers of the surface, and reduce the irregular hyperplasia of fibrocartilage layer. In conclusion, by comparing the properties of different 3B-PEG IH, 20 wt% PLCL-PEG-PLCL hydrogel was selected as the most appropriate material. PLCL-PEG-PLCL/Nell-1 composite could reverse osteochondral damage caused by TMJOA, Nfatc1-Runx3 signaling pathway may play a role in it. This study may provide a novel, minimally-invasive therapeutic strategy for the clinical treatment of TMJOA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
PHW完成签到,获得积分10
刚刚
小_n完成签到,获得积分10
1秒前
小欧文发布了新的文献求助10
1秒前
2秒前
田様应助科研糊涂神采纳,获得10
2秒前
兔兔发布了新的文献求助10
2秒前
3秒前
4秒前
Fury发布了新的文献求助20
4秒前
ruyi发布了新的文献求助10
4秒前
淡淡菠萝发布了新的文献求助10
5秒前
hhhhhhh发布了新的文献求助10
5秒前
liars完成签到 ,获得积分10
7秒前
7秒前
而发的发布了新的文献求助10
8秒前
11秒前
beckvanm完成签到,获得积分10
11秒前
HP发布了新的文献求助10
11秒前
调皮的戎发布了新的文献求助50
11秒前
14秒前
14秒前
15秒前
犹豫的踏歌完成签到,获得积分10
16秒前
ghostR发布了新的文献求助10
18秒前
18秒前
一朵云发布了新的文献求助10
20秒前
20秒前
21秒前
raziel完成签到,获得积分10
22秒前
23秒前
www完成签到 ,获得积分10
24秒前
nieinei完成签到 ,获得积分10
24秒前
24秒前
somous发布了新的文献求助200
24秒前
zhuo发布了新的文献求助10
28秒前
29秒前
30秒前
30秒前
科研狗头军师完成签到,获得积分10
31秒前
32秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3140698
求助须知:如何正确求助?哪些是违规求助? 2791571
关于积分的说明 7799545
捐赠科研通 2447907
什么是DOI,文献DOI怎么找? 1302182
科研通“疑难数据库(出版商)”最低求助积分说明 626459
版权声明 601194